Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review

Alzheimer’s disease (AD) is a remarkable challenge for healthcare in the 21st century. Since 2017, deep learning models with transfer learning approaches have been gaining recognition in AD detection, and progression prediction by using neuroimaging biomarkers. This paper presents a systematic revie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Deevyankar Agarwal, Gonçalo Marques, Isabel de la Torre-Díez, Manuel A. Franco Martin, Begoña García Zapiraín, Francisco Martín Rodríguez
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/e15e4398a09c4a6aa4937f3d47427ed6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e15e4398a09c4a6aa4937f3d47427ed6
record_format dspace
spelling oai:doaj.org-article:e15e4398a09c4a6aa4937f3d47427ed62021-11-11T19:13:24ZTransfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review10.3390/s212172591424-8220https://doaj.org/article/e15e4398a09c4a6aa4937f3d47427ed62021-10-01T00:00:00Zhttps://www.mdpi.com/1424-8220/21/21/7259https://doaj.org/toc/1424-8220Alzheimer’s disease (AD) is a remarkable challenge for healthcare in the 21st century. Since 2017, deep learning models with transfer learning approaches have been gaining recognition in AD detection, and progression prediction by using neuroimaging biomarkers. This paper presents a systematic review of the current state of early AD detection by using deep learning models with transfer learning and neuroimaging biomarkers. Five databases were used and the results before screening report 215 studies published between 2010 and 2020. After screening, 13 studies met the inclusion criteria. We noted that the maximum accuracy achieved to date for AD classification is 98.20% by using the combination of 3D convolutional networks and local transfer learning, and that for the prognostic prediction of AD is 87.78% by using pre-trained 3D convolutional network-based architectures. The results show that transfer learning helps researchers in developing a more accurate system for the early diagnosis of AD. However, there is a need to consider some points in future research, such as improving the accuracy of the prognostic prediction of AD, exploring additional biomarkers such as tau-PET and amyloid-PET to understand highly discriminative feature representation to separate similar brain patterns, managing the size of the datasets due to the limited availability.Deevyankar AgarwalGonçalo MarquesIsabel de la Torre-DíezManuel A. Franco MartinBegoña García ZapiraínFrancisco Martín RodríguezMDPI AGarticleAlzheimer’s diseaseneuroimaging biomarkersmagnetic resonance imagingpositron emission tomographytransfer learningChemical technologyTP1-1185ENSensors, Vol 21, Iss 7259, p 7259 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer’s disease
neuroimaging biomarkers
magnetic resonance imaging
positron emission tomography
transfer learning
Chemical technology
TP1-1185
spellingShingle Alzheimer’s disease
neuroimaging biomarkers
magnetic resonance imaging
positron emission tomography
transfer learning
Chemical technology
TP1-1185
Deevyankar Agarwal
Gonçalo Marques
Isabel de la Torre-Díez
Manuel A. Franco Martin
Begoña García Zapiraín
Francisco Martín Rodríguez
Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
description Alzheimer’s disease (AD) is a remarkable challenge for healthcare in the 21st century. Since 2017, deep learning models with transfer learning approaches have been gaining recognition in AD detection, and progression prediction by using neuroimaging biomarkers. This paper presents a systematic review of the current state of early AD detection by using deep learning models with transfer learning and neuroimaging biomarkers. Five databases were used and the results before screening report 215 studies published between 2010 and 2020. After screening, 13 studies met the inclusion criteria. We noted that the maximum accuracy achieved to date for AD classification is 98.20% by using the combination of 3D convolutional networks and local transfer learning, and that for the prognostic prediction of AD is 87.78% by using pre-trained 3D convolutional network-based architectures. The results show that transfer learning helps researchers in developing a more accurate system for the early diagnosis of AD. However, there is a need to consider some points in future research, such as improving the accuracy of the prognostic prediction of AD, exploring additional biomarkers such as tau-PET and amyloid-PET to understand highly discriminative feature representation to separate similar brain patterns, managing the size of the datasets due to the limited availability.
format article
author Deevyankar Agarwal
Gonçalo Marques
Isabel de la Torre-Díez
Manuel A. Franco Martin
Begoña García Zapiraín
Francisco Martín Rodríguez
author_facet Deevyankar Agarwal
Gonçalo Marques
Isabel de la Torre-Díez
Manuel A. Franco Martin
Begoña García Zapiraín
Francisco Martín Rodríguez
author_sort Deevyankar Agarwal
title Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
title_short Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
title_full Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
title_fullStr Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
title_full_unstemmed Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
title_sort transfer learning for alzheimer’s disease through neuroimaging biomarkers: a systematic review
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/e15e4398a09c4a6aa4937f3d47427ed6
work_keys_str_mv AT deevyankaragarwal transferlearningforalzheimersdiseasethroughneuroimagingbiomarkersasystematicreview
AT goncalomarques transferlearningforalzheimersdiseasethroughneuroimagingbiomarkersasystematicreview
AT isabeldelatorrediez transferlearningforalzheimersdiseasethroughneuroimagingbiomarkersasystematicreview
AT manuelafrancomartin transferlearningforalzheimersdiseasethroughneuroimagingbiomarkersasystematicreview
AT begonagarciazapirain transferlearningforalzheimersdiseasethroughneuroimagingbiomarkersasystematicreview
AT franciscomartinrodriguez transferlearningforalzheimersdiseasethroughneuroimagingbiomarkersasystematicreview
_version_ 1718431616560267264